Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DOCN vs MRNA✓SelectedUSD · MRNADOCN vs MRNA performance historyLatest closeAs of+0.71%11/17
Stock and ETF performance explorer

DOCN vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+86.9%
MRNA return
+50.7%
Excess return
+36.2%
Maximum drawdown
-84.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.7%-3.9%+4.6%+1.1%
7D-0.1%-17.6%+17.5%+1.9%
30D-19.5%-5.1%-14.4%-19.2%
3M-41.3%+220.8%-262.1%-53.3%
6M-48.7%+321.7%-370.4%-63.0%
YTD+65.1%+601.3%-536.2%-0.9%
1Y+78.3%+735.2%-656.9%+0.9%
3Y+174.9%+170.5%+4.3%+95.6%
5Y-38.4%-14.6%-23.8%-44.1%
All+86.9%+50.7%+36.2%+29.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling